IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · IEX Real-Time Price · USD
1.620
+0.040 (2.53%)
Jul 22, 2024, 10:28 AM EDT - Market open
IO Biotech Employees
IO Biotech had 68 employees as of December 31, 2023. The number of employees increased by 11 or 19.30% compared to the previous year.
Employees
68
Change (1Y)
11
Growth (1Y)
19.30%
Revenue / Employee
n/a
Profits / Employee
-$1,301,412
Market Cap
107.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 68 | 11 | 19.30% |
| Dec 31, 2022 | 57 | 25 | 78.13% |
| Dec 31, 2021 | 32 | 21 | 190.91% |
| Dec 31, 2020 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| So-Young International | 1,357 |
| FibroGen | 486 |
| InterCure | 270 |
| Adicet Bio | 143 |
| Cardiff Oncology | 32 |
| Zentek | 24 |
| Eledon Pharmaceuticals | 20 |
| Coya Therapeutics | 8 |
IOBT News
- 2 months ago - IO Biotech to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 3 months ago - IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 3 months ago - IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness - GlobeNewsWire
- 3 months ago - IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103 - GlobeNewsWire
- 3 months ago - IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer - GlobeNewsWire
- 4 months ago - IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 4 months ago - IO Biotech Announces 2023 Fourth-Quarter and Year-End Results - GlobeNewsWire